FDA Inspection 1123105 — Enkhtsetseg Purev MD
The FDA completed an inspection of Enkhtsetseg Purev MD on April 1, 2020 in Burlingame, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 1, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Burlingame, CA (United States)
Additional Details
Clinical Investigator (CI)